11 Nov 2009 17:46
RNS Number : 3775C
e-Therapeutics plc
11 November 2009
e-Therapeutics plc
Holdings in Company
e-Therapeutics plc (the "Company") (AIM:ETX) received notification on 11 November 2009 that pursuant to the placing announced on 2 November, Gartmore Investment Limited holds 6,541,000 ordinary shares representing approximately 9.998% of the issued share capital of the Company.
The Company has 65,420,292 ordinary shares with a nominal value of 0.1p with voting rights in issue, none of which are held in treasury.
| For more information: | |
| e-Therapeutics plc | www.etherapeutics.co.uk |
| Malcolm Young malcolm@etherapeutics.co.uk | +44 (0) 191 233 1317 |
| Nominated Advisor & Broker: Canaccord Adams Ltd | www.canaccordadams.com |
| Robert Finlay Henry Fitzgerald-O'Connor
| +44 (0) 20 7050 6500 |
This information is provided by RNS
The company news service from the London Stock Exchange
ETX.L (ETX)